enteroviru
belong
picornavirida
famili
enteroviru
genu
singlestrand
positivesens
rna
viru
pathogen
caus
agent
hand
foot
mouth
diseas
hfmd
especi
major
caus
sever
hfmd
sinc
first
report
unit
state
outbreak
report
around
world
particularli
asiapacif
region
recent
year
china
caus
sever
hfmd
outbreak
fuyang
anhui
provinc
sinc
becom
epidem
problem
frequenc
sever
hfmd
shown
increas
annual
trend
pose
seriou
threat
children
health
social
stabil
china
howev
effect
therapi
current
avail
treatment
infect
studi
need
elucid
pathogenesi
genom
encod
eleven
protein
includ
four
viral
capsid
protein
seven
nonstructur
protein
among
viral
protein
viral
proteas
demonstr
play
import
role
virushost
interact
pathogenesi
report
hijack
host
cell
gene
express
cleav
eukaryot
initi
factor
poli
bind
protein
pabp
also
report
antagon
host
innat
immun
downregul
interferon
receptor
cleav
mitochondri
antivir
signal
protein
mav
report
mediat
viral
immuneevas
target
mani
key
compon
host
innat
immun
includ
trif
complex
moreov
also
report
disrupt
host
cell
gene
express
cleav
gener
previou
studi
concern
viral
proteas
focus
innat
immun
gene
express
mammalian
cell
approxim
onethird
protein
assembl
matur
protein
er
process
tightli
monitor
er
protein
qualiti
control
erqc
system
comprehens
mainten
mechan
highli
crowd
protein
er
system
ensur
correctli
fold
assembl
protein
reach
ultim
destin
erqc
system
achiev
function
via
sever
molecular
chaperon
two
degrad
pathway
autophagylysosomemedi
autophag
degrad
ubiquitinproteasomemedi
erassoci
degrad
erad
pathway
autophagi
remov
protein
aggreg
damag
organel
doubl
membran
vesicl
degrad
autolysosom
sever
virus
util
alter
cellular
autophagi
facilit
replic
includ
hepat
c
viru
hcv
coronaviru
dengu
viru
influenza
viru
polioviru
pv
coxsackieviru
huang
et
al
previou
studi
demonstr
also
induc
cellular
autophagi
exploit
autophagi
replic
howev
remain
unknown
whether
erad
also
affect
involv
replic
erad
process
facilit
degrad
termin
misfold
misassembl
metabol
regul
protein
er
retrotransloc
cytosol
degrad
ubiquitinproteasom
system
process
consist
four
coupl
step
substrat
recognit
ii
retrotransloc
iii
ubiquitin
iv
proteasomemedi
degrad
sinc
erad
key
cellular
machineri
ensur
correct
cell
function
unsurpris
virus
manipul
process
benefit
previou
studi
demonstr
differ
virus
affect
exploit
erad
process
differ
manner
four
reason
virus
exploit
erad
first
escap
immun
surveil
system
elimin
immun
molecul
exampl
includ
herp
viru
human
immunodefici
viru
hiv
second
virus
take
advantag
erad
achiev
membran
penetr
intact
virus
er
cytosol
simian
viru
human
bk
viru
murin
polymaviru
third
virus
promot
erad
tune
hijack
edemosom
support
replic
includ
coronavirus
sever
acut
respiratori
syndrom
coronaviru
sarscov
mous
hepat
viru
mhv
final
virus
activ
erad
degrad
viral
glycoprotein
therebi
reduc
viral
particl
maintain
chronic
infect
statu
exampl
includ
hepat
b
viru
hbv
hepat
c
viru
hcv
howev
despit
numer
studi
mention
report
investig
relationship
picornavirus
erad
demonstr
infect
inhibit
cellular
erad
process
multipl
key
erad
molecul
via
proteas
erad
compon
involv
replic
studi
reveal
novel
relationship
cellular
erad
thu
shed
light
pathogenesi
erad
autophag
degrad
two
facet
host
protein
qualiti
control
system
biolog
process
exploit
variou
infecti
pathogen
surviv
prolifer
strategi
previou
studi
also
demonstr
take
advantag
host
autophagi
prolifer
howev
remain
unknown
whether
affect
modul
host
erad
machineri
address
question
first
categor
erad
substrat
accord
differ
chaperon
system
establish
stabl
cell
line
ectop
express
substrat
two
type
erad
substrat
accord
vari
chaperon
system
calnexin
cnx
calreticulin
crt
depend
substrat
bipdepend
substrat
differ
type
substrat
may
dispos
distinct
erad
subpathway
differ
molecul
may
involv
first
investig
degrad
two
wellcharacter
cnxcrtdepend
erad
substrat
cterminu
shh
shhc
antitrypsin
null
hong
kong
nhk
rhabdomyosarcoma
rd
cell
stabli
express
shh
nhk
mock
infect
infect
treat
protein
synthesi
inhibitor
cycloheximid
chx
differ
time
accord
pretest
halflif
western
blot
use
measur
express
substrat
level
shhc
nhk
gradual
decreas
chxtreat
mockinfect
cell
timedepend
manner
howev
decreas
chx
chase
significantli
inhibit
cell
fig
indic
may
inhibit
erad
shhc
nhk
confirm
inhibitori
effect
shh
nhk
stabl
cell
line
treat
tunicamycin
tun
inhibitor
nglycosyl
modif
fate
alreadi
synthes
glycosyl
substrat
monitor
mockinfect
cell
stabli
express
shh
nhk
treatment
tun
led
timedepend
decreas
glycosyl
shhc
nhk
accompani
increas
level
newli
synthes
nonglycosyl
form
howev
infect
cell
degrad
glycosyl
shhc
nhk
dramat
inhibit
fig
confirm
inhibitori
effect
erad
glycosyl
shhc
nhk
howev
worth
note
de
novo
synthes
nonglycosyl
form
shhc
nhk
detect
mockinfect
cell
infect
cell
fig
indic
de
novo
synthesi
shh
nhk
inhibit
infect
next
erad
bip
substrat
infect
evalu
transthyretin
amino
acid
mutat
g
ttr
nonsecretori
immunoglobulin
kappatyp
light
chain
lc
select
repres
ttr
nonglycosyl
solubl
secretori
protein
ttr
destabil
mutant
ttr
subject
erad
lc
unassembl
immunoglobulin
light
chain
degrad
erad
rd
cell
stabli
express
ttr
lc
treat
chx
degrad
assess
degrad
substrat
remark
inhibit
timedepend
manner
infect
fig
suggest
infect
also
inhibit
erad
bip
substrat
worth
note
high
molecular
weight
band
ttr
visibl
fig
demonstr
glycosyl
form
ttr
treat
cell
lysat
glycosidas
pngase
f
fig
cell
molecular
weight
glycosyl
ttr
decreas
specul
due
extens
mannos
trim
sinc
experi
perform
use
stabl
cell
line
ectop
express
differ
substrat
next
assess
whether
infect
could
inhibit
degrad
endogen
substrat
therefor
degrad
coreglycosyl
cg
report
constitut
endogen
substrat
examin
infect
chx
chase
assay
show
cg
gradual
degrad
timedepend
manner
chxtreat
mockinfect
rd
cell
howev
degrad
partial
inhibit
infect
fig
suggest
infect
also
inhibit
erad
cellular
endogen
substrat
consid
induc
cell
apoptosi
experi
perform
infect
infect
combin
chx
treatment
h
check
cell
apoptosi
rd
cell
condit
result
show
proport
apoptosi
cell
infect
h
combin
treatment
chx
last
h
slightli
upregul
proport
fig
taken
togeth
result
demonstr
infect
inhibit
erad
differ
type
substrat
includ
cnxcrtdepend
glycosyl
substrat
bipdepend
nonglycosyl
substrat
cellular
constitut
endogen
express
substrat
sinc
erad
process
detect
misfold
protein
er
extract
cytosol
proteasom
degrad
next
assess
locat
erad
substrat
cell
first
shhc
use
substrat
shhc
glycosyl
protein
undergo
deglycosyl
retrotransloc
cytosol
accumul
deglycosyl
shhc
proteasom
inhibit
reflect
retrotransloc
degre
cell
treat
proteasom
inhibitor
deglycosyl
shhc
detect
either
mock
cell
howev
cell
treat
deglycosyl
shhc
visibl
lowmolecular
weight
band
mockinfect
cell
bare
detect
cell
fig
suggest
retrotransloc
shhc
inhibit
infect
shhc
could
trap
insid
er
lumen
confirm
conclus
previous
report
dislocationdepend
reconstitut
gfp
drgfp
assay
use
evalu
differ
substrat
principl
system
illustr
fig
briefli
gfp
molecul
split
two
fragment
ctermin
remain
strand
link
erad
substrat
express
er
lumen
express
cytosol
substrat
retrotransloc
cytosol
reassembl
result
gfp
signal
detect
coupl
proteasom
degrad
inhibit
fig
first
drgfp
assay
use
determin
locat
shhc
cell
result
show
cell
treat
gfp
signal
observ
either
mockinfect
cell
howev
reconstitut
gfp
signal
could
detect
mockinfect
cell
cell
fig
suggest
inhibit
retrotransloc
activ
shhc
substrat
trap
insid
er
infect
method
also
use
test
retrotransloc
activ
nhk
ttr
infect
similar
result
obtain
fig
drgfp
assay
use
evalu
substrat
lc
sinc
previou
studi
report
lc
retain
er
lumen
transloc
cytosol
cell
treat
proteasom
inhibitor
experi
perform
rd
cell
express
differ
substrat
infect
h
also
use
flow
cytometri
monitor
cell
apoptosi
situat
result
show
infect
h
caus
apoptosi
cell
combin
treatment
last
h
slightli
downregul
proport
fig
taken
togeth
result
demonstr
cnxdepend
glycosyl
substrat
bipdepend
nonglycosyl
substrat
trap
insid
er
infect
therefor
could
retrotransloc
cytosol
undergo
subsequ
proteasom
degrad
result
demonstr
inhibit
degrad
differ
erad
substrat
sinc
differ
substrat
degrad
distinct
subpathway
like
inhibit
erad
multipl
target
one
share
key
point
clarifi
specif
molecular
mechan
eradrel
molecul
categor
differ
function
kinet
studi
perform
measur
express
infect
molecul
examin
classifi
four
categori
recognit
factor
calnexin
calreticulin
bip
retrotransloc
factor
herp
ubiquitin
factor
proteasom
degrad
factor
vimp
fig
expect
infect
downregul
express
sever
molecul
timedepend
manner
includ
herp
vimp
fig
among
two
band
seem
like
cleavag
product
could
detect
around
kda
molecular
weight
intens
increas
infect
proceed
cleavag
band
also
detect
blot
blot
herp
vimp
fig
previou
studi
report
three
ubiquitinconjug
enzym
function
mammalian
erad
form
pair
consid
princip
cellular
erad
clarifi
precis
mechan
cleav
investig
whether
viral
proteas
particip
process
viral
proteas
respons
cleav
polyprotein
precursor
obtain
matur
viral
protein
increas
amount
evid
demonstr
could
cleav
variou
host
factor
facilit
viral
replic
first
cell
transfect
plasmid
encod
proteasedead
mutant
cleavag
detect
western
blot
overexpress
could
cleav
dosedepend
manner
cleavag
band
molecular
weight
cell
fig
result
also
achiev
vitro
cleavag
assay
recombin
proteasedead
mutant
fig
also
test
role
cleavag
result
show
cleavag
band
detect
cell
fig
suggest
cleav
infect
next
assess
whether
caus
erad
inhibit
rd
cell
stabli
express
shh
transfect
increas
dose
plasmid
encod
flagtag
western
blot
perform
monitor
degrad
shhc
chx
chase
result
show
shhc
degrad
inhibit
gradual
increas
express
fig
howev
inhibitori
effect
potent
infect
might
due
limit
transfect
effici
overexpress
could
cleavag
one
factor
inhibit
erad
factor
could
also
involv
overal
result
suggest
cleavag
could
crucial
mechan
inhibit
erad
identifi
cleavag
site
cell
cotransfect
plasmid
encod
ctermin
flagtag
cleavag
monitor
use
antibodi
flag
antibodi
mous
monoclon
antibodi
unknown
epitop
result
show
kda
cleavag
band
could
recogn
antibodi
flag
antibodi
fig
indic
cleavag
band
ntermin
cleavag
fragment
molecular
weight
cleavag
fragment
suggest
cleavag
site
might
locat
region
amino
acid
fig
sinc
picornaviru
preferenti
cleav
glutamineglycin
qg
glutaminealanin
qa
glutamineserin
qs
bond
viral
polyprotein
cellular
target
panel
sitedirect
mutant
q
mutat
within
amino
acid
aa
region
construct
cell
cotransfect
mutant
map
cleavag
site
illustr
fig
mutant
could
cleav
howev
cleavag
band
mutant
shift
molecular
weight
kda
fig
indic
glutamin
one
cleavag
site
anoth
cleavag
site
exist
locat
closer
cterminu
identifi
remain
cleavag
site
new
panel
doublesit
mutant
q
construct
within
aa
region
base
mutant
seri
mutant
reveal
doublesit
mutant
could
cleav
howev
cleavag
band
chang
cell
transfect
mutant
indic
cleavag
site
fig
confirm
result
third
round
screen
conduct
use
triplesit
q
mutant
gener
base
includ
result
show
triplesit
mutant
total
resist
cleavag
thu
identifi
second
third
cleavag
site
fig
taken
togeth
result
demonstr
cleav
site
locat
cytoplasm
side
cleavag
point
lead
releas
catalyt
domain
cytosol
inact
er
membran
cleavag
site
identifi
reanalyz
result
fig
specul
cleavag
fragment
accompani
phosphoryl
form
lower
migrat
speed
also
confirm
treat
cell
lysat
phosphatas
detect
cleavag
result
show
dualband
cleav
chang
singleband
treat
phosphatas
fig
next
mechan
behind
decreas
express
herp
vimp
examin
herp
whose
express
strongli
induc
unfold
protein
respons
upr
involv
turnov
erad
substrat
particip
build
disloc
machineri
around
fast
turnov
explor
reason
behind
herp
reduct
first
assess
whether
reduct
herp
caus
acceler
degrad
block
synthesi
mock
rd
cell
treat
er
stress
induc
thapsigargin
tg
tunicamycin
tun
induc
herp
express
degre
upregul
compar
mock
cell
tg
tun
could
induc
herp
express
effici
mockinfect
cell
especi
cell
treat
er
stress
induc
combin
proteasom
inhibitor
howev
treatment
induc
less
herp
express
cell
impli
infect
may
inhibit
de
novo
synthesi
herp
herp
degrad
via
proteasom
degrad
fig
cell
apoptosi
cell
infect
cell
combin
differ
chemic
treatment
shown
fig
also
check
obviou
differ
observ
differ
group
fig
sinc
inhibit
host
gene
express
protein
translat
level
next
assess
whether
herp
reduct
caus
block
protein
translat
test
hypothesi
impact
mrna
transcript
check
mock
rd
cell
treat
tg
tun
herp
mrna
express
assess
use
realtim
pcr
tg
tun
induc
herp
express
effici
mockinfect
cell
extent
upregul
reduc
cell
howev
differ
basal
herp
express
mock
cell
fig
suggest
might
inhibit
basal
herp
synthesi
translat
level
inhibit
tg
tuninduc
herp
synthesi
transcript
translat
level
inhibit
protein
translat
host
cell
cleav
mani
host
factor
relat
translat
process
includ
eukaryot
translat
initi
factor
polya
bind
protein
pabp
therefor
assess
whether
block
protein
synthesi
herp
previous
report
cell
line
stabli
express
rna
polymeras
effect
avoid
difficulti
express
eukaryot
cell
use
gfp
proteasedead
mutant
control
tg
tun
induc
herp
express
much
weaker
extent
cell
compar
control
cell
fig
suggest
could
inhibit
herp
synthesi
next
mechan
vimp
reduct
infect
investig
vimp
valosincontain
protein
vcp
interact
membran
protein
import
compon
erad
complex
recruit
cofactor
er
membran
retrotransloc
chx
chase
assay
reveal
vimp
shortliv
protein
similar
herp
fig
therefor
possibl
inhibit
vimp
herp
express
via
similar
mechan
confirm
cell
line
transfect
vimp
express
monitor
mrna
protein
level
result
show
differ
vimp
mrna
express
gfp
cell
fig
howev
protein
express
vimp
significantli
downregul
cell
gfp
transfect
cell
protein
level
dosedepend
manner
fig
suggest
also
inhibit
protein
synthesi
vimp
taken
togeth
result
demonstr
inhibit
protein
synthesi
herp
vimp
although
picornavirus
well
known
inhibit
capdepend
host
cell
translat
cleav
sever
host
factor
relat
translat
process
thought
effect
host
cell
protein
express
mainli
embodi
shortliv
protein
like
herp
vimp
studi
also
includ
cmyc
anoth
report
shortliv
protein
shortliv
control
detect
express
transfect
cell
expect
express
cmyc
downregul
cell
fig
clarifi
signific
inhibit
cellular
erad
first
examin
whether
key
erad
compon
could
impact
lifecycl
although
herp
viral
target
cellular
erad
result
show
knockdown
chang
viral
protein
express
infect
cell
fig
check
viral
rna
herp
knockdown
cell
result
show
viral
rna
replic
affect
knockdown
fig
use
sirna
silenc
differ
erad
compon
besid
herp
check
role
replic
result
show
deplet
atpas
remark
inhibit
replic
deplet
cofactor
slight
inhibitori
effect
fig
suggest
complex
especi
critic
host
factor
requir
replic
explor
whether
atpas
activ
requir
replic
dbeq
revers
small
molecul
inhibitor
domin
neg
mutant
use
pretreat
rd
cell
dbeq
transfect
rd
cell
remark
attenu
infect
dosedepend
manner
fig
suggest
atpas
activ
requir
replic
accord
result
hypothes
may
hijack
disabl
erad
pathway
promot
replic
test
hypothesi
examin
whether
distribut
chang
multicolor
fluoresc
confoc
microscopi
distribut
chang
significantli
cell
origin
evenli
distribut
pattern
chang
nonuniform
state
accumul
around
wrinkl
nuclei
addit
coloc
fig
suggest
jointli
particip
replic
next
endogen
coimmunoprecipit
experi
perform
cell
antibodi
result
show
immunoprecipit
antibodi
control
igg
fig
indic
protein
may
interact
infect
cell
sinc
protein
polioviru
also
report
interact
interact
observ
infect
cell
may
indirectli
mediat
viral
protein
test
possibl
exogen
coimmunoprecipit
experi
perform
cell
cotransfect
plasmid
encod
hatag
protein
flagtag
protein
result
show
also
coimmunoprecipit
fig
indic
could
interact
aid
viral
protein
howev
result
exclud
possibl
viral
protein
also
interact
taken
togeth
result
strongli
suggest
coexist
might
viral
protein
involv
replic
furthermor
propos
site
aggreg
viral
protein
infect
cell
might
site
viral
replic
mani
rna
virus
rearrang
intracellular
membran
gener
replic
organel
ro
ro
picornavirus
report
form
ergolgi
interfac
util
host
factor
includ
phosphatidylinositol
adpribosyl
factor
golgi
brefeldin
aresist
guanin
nucleotid
exchang
factor
test
whether
similar
ro
also
form
cell
first
check
whether
abovement
host
factor
also
involv
lifecycl
sirna
knockdown
result
show
knock
either
inhibit
propag
fig
suggest
induc
similar
exactli
ro
picornavirus
next
immunofluoresc
stain
perform
assess
whether
intracellular
distribut
chang
infect
cell
whether
coloc
factor
redistribut
perinuclear
region
infect
cell
coloc
fig
demonstr
site
coloc
host
factor
ro
infect
cell
coloc
assay
perform
three
molecul
coloc
perinuclear
region
fig
suggest
aggreg
foci
perinuclear
region
actual
viral
ro
observ
ro
cell
electron
microscopi
perform
use
highpressur
freez
hpf
freezesubstitut
fs
method
cell
larg
quantiti
membran
vesicl
accumul
perinuclear
region
nm
diamet
surround
singl
doublemembran
vesicl
close
contact
swell
er
fig
indic
ro
may
origin
er
confirm
er
membran
er
molecul
hijack
form
viral
ro
distribut
reticulon
er
membran
molecul
assess
use
immunofluoresc
result
show
redistribut
concentr
perinuclear
foci
coloc
protein
cell
fig
suggest
redistribut
er
membran
viral
ro
infect
taken
togeth
data
suggest
ro
close
interrel
er
membran
ro
origin
er
thu
ration
infer
inhibit
cellular
erad
hijack
erad
compon
take
advantag
erderiv
membran
compon
benefit
replic
studi
extens
investig
impact
erad
report
novel
relationship
viru
cellular
erad
find
summar
fig
previou
studi
report
relationship
virus
cellular
erad
common
virus
use
erad
machineri
benefit
howev
use
total
differ
strategi
influenc
cellular
erad
inhibit
erad
via
viral
proteas
thoroughli
suppress
physiolog
erad
multipl
point
hijack
host
factor
util
erderiv
membran
compon
disabl
erad
machineri
form
replic
organel
studi
found
viral
protein
express
viral
rna
replic
chang
herp
knockdown
cell
although
degrad
erad
substrat
inhibit
thought
damag
er
caus
herp
knockdown
rel
mild
compar
infect
er
membran
rearrang
situat
howev
infect
cell
erad
inhibit
multipl
point
er
homeostasi
suffer
seriou
damag
inevit
caus
chang
er
lead
membran
rearrang
allow
virus
take
advantag
er
membran
errel
host
factor
conveni
studi
reveal
novel
function
proteas
picornaviru
proteas
influenc
mani
cellular
process
previou
studi
mainli
focus
innat
immun
gene
express
knowledg
first
studi
reveal
role
viral
proteas
erad
process
howev
futur
studi
need
determin
whether
viral
proteas
function
erad
ubiquitinconjug
enzym
ligas
work
cooper
ubiquitin
substrat
date
three
five
princip
identifi
mammalian
erad
system
among
form
pair
form
pair
two
pair
consid
main
executor
substrat
ubiquitin
erad
distinct
substrat
specif
determin
current
result
reveal
infect
caus
cleavag
downregul
thu
total
destroy
pair
also
investig
pair
obviou
chang
two
molecul
infect
fig
indic
pair
key
ubiquitin
element
target
infect
attempt
reconstitut
function
erad
system
cell
cotransfect
cell
mutant
wt
howev
could
rescu
inhibit
erad
process
fig
suggest
inhibit
erad
comprehens
manner
involv
multipl
factor
decreas
cleavag
found
studi
exampl
also
check
role
cleavag
result
exclud
role
fig
futur
work
focu
specif
mechan
studi
identifi
key
ubiquitinconjug
enzym
erad
knockdown
sirna
inhibit
degrad
erad
substrat
test
howev
one
recent
studi
hagiwara
et
al
report
acceler
degrad
nhk
cell
could
downregul
erad
enhanc
discrep
might
caus
differ
silenc
effici
method
use
two
group
use
sirna
knock
hagiwara
et
al
use
knockout
mef
describ
hagiwara
et
al
littl
suffic
properli
regul
erad
enhanc
use
sirna
knockdown
complet
remain
suffici
maintain
proper
express
level
erad
enhanc
moreov
cell
may
compens
complex
substitut
degrad
erad
substrat
okudashimizu
et
al
kni
et
al
report
conflict
result
role
herp
degrad
differ
substrat
current
studi
explor
involv
herp
differ
erad
pathway
result
consist
kni
colleagu
specif
herp
involv
erad
bip
substrat
lc
calnexin
substrat
nhk
anoth
calnexin
substrat
shhc
suggest
signatur
bind
chaperon
glycosyl
determin
substrat
specif
herp
critic
constitu
erad
turnov
mediat
erad
tune
strategi
herp
regul
erad
previou
studi
demonstr
respons
herp
degrad
recoveri
er
stress
howev
mechan
herp
degrad
physiolog
condit
unknown
current
studi
identifi
key
particip
herp
degrad
sinc
silenc
increas
intracellular
level
herp
fig
silenc
effect
fig
also
tri
identifi
partner
particip
herp
degrad
although
candid
includ
unfortun
could
draw
definit
conclus
herp
upregul
silenc
fig
nevertheless
specul
involv
degrad
herp
overexpress
dominantneg
mutant
increas
herp
express
compar
wt
fig
howev
unclear
silenc
littl
impact
herp
wherea
overexpress
dramat
increas
herp
level
postul
associ
herp
key
determin
intracellular
herp
express
specif
silenc
herp
downregul
overexpress
herp
upregul
futur
studi
need
verifi
hypothesi
clarifi
specif
mechan
herp
degrad
previou
studi
demonstr
host
factor
viral
replic
arita
et
al
demonstr
requir
polioviru
replic
involv
cellular
protein
secret
pathway
panda
et
al
identifi
conserv
regul
sindbi
viru
entri
recent
studi
demonstr
essenti
hcv
replic
propos
involv
assembl
hcv
replicas
addit
wu
et
al
identifi
cellular
factor
involv
replic
use
genomewid
rnai
screen
current
studi
propos
hijack
disabl
erad
machineri
identifi
host
factor
replic
demonstr
coloc
viral
protein
ro
studi
support
role
viral
lifecycl
disclos
origin
particip
format
ro
howev
remain
unclear
function
ro
propos
might
particip
replic
complex
assembl
membran
rearrang
via
aaaatpas
activ
studi
tri
distinguish
ro
edemosom
accord
previou
report
virusinduc
ro
origin
edemosom
common
featur
doublemembran
vesicl
coat
nonlipid
silenc
significantli
inhibit
viru
propag
howev
ro
observ
electron
microscopi
includ
singl
doublemembran
vesicl
singlemembran
vesicl
also
check
distribut
cell
result
show
chang
infect
fig
therefor
conclud
ro
differ
edemosom
influenc
cellular
erad
machineri
via
total
novel
differ
mechan
previou
studi
reveal
picornaviru
form
replic
organel
ergolgi
interfac
took
advantag
membran
host
factor
er
golgi
origin
unclear
picornaviru
tend
choos
specif
element
host
cell
replic
util
current
studi
found
inhibit
cellular
erad
critic
function
er
maintain
homeostasi
inhibit
erad
inevit
caus
er
deform
may
lead
membran
rearrang
allow
virus
take
advantag
host
membran
host
factor
conveni
taken
togeth
studi
demonstr
novel
relationship
cellular
erad
system
identifi
new
host
factor
essenti
replic
redistribut
coloc
viral
protein
ro
find
provid
potenti
target
antivir
treatment
infect
rhabdomyosarcoma
rd
cell
human
embryon
kidney
cell
purchas
atcc
cultur
mem
modifi
eagl
medium
dmem
dulbecco
modifi
eagl
medium
respect
supplement
fetal
bovin
serum
fb
penicillin
unitsml
streptomycin
mgml
cell
describ
previou
studi
cultur
dmem
supplement
fb
mgml
cell
maintain
humidifi
atmospher
air
fuyang
strain
genbank
access
propag
rd
cell
rd
cell
stabli
express
shh
nhk
ttr
lc
obtain
transfect
rd
cell
correspond
plasmid
follow
select
use
mgml
follow
antibodi
use
studi
antigfp
antiha
antiflag
anticalnexin
purchas
sigmaaldrich
antibip
anticalreticulin
antivimp
purchas
cell
signal
technolog
purchas
genetex
anticmyc
purchas
proteintech
purchas
abcam
antiherp
obtain
santa
cruz
biotechnolog
enzo
life
scienc
origen
respect
purchas
millipor
abnova
respect
correspond
irdy
secondari
antibodi
obtain
licor
bioscienc
fluorescencelabel
secondari
antibodi
use
immunostain
purchas
jackson
immunoresearch
antibodi
gener
rabbit
mice
use
recombin
protein
immunogen
dbeq
chx
dtt
tg
purchas
sigmaaldrich
dapi
lipofectamin
lipofectamin
rnaimax
purchas
invitrogen
tun
purchas
cell
signal
technolog
calbiochem
respect
purchas
amresco
lambda
protein
phosphatas
purchas
new
england
biolab
purchas
origen
nhk
cdna
kindli
provid
dr
richard
n
sifer
baylor
colleg
medicin
usa
lc
plasmid
gift
dr
linda
hendershot
st
jude
children
research
hospit
usa
construct
gift
dr
shengyun
fang
univers
maryland
school
medicin
usa
gener
gift
dr
shihyen
lo
tzu
chi
univers
taiwan
china
construct
lc
cdna
templat
amplifi
pcr
clone
sgfi
mlui
site
vector
construct
pcmvttr
shh
ttr
sequenc
amplifi
pcr
clone
ecori
sali
site
construct
plasmid
rna
rd
cell
revers
transcrib
cdna
cdna
amplifi
pcr
clone
sali
xbai
site
pvrc
construct
sequenc
amplifi
pcr
clone
sgfi
mlui
site
construct
cdna
amplifi
pcr
clone
sali
xbai
site
pvrc
vector
plasmid
express
mutant
gener
sitedirect
mutagenesi
describ
previous
cell
lyse
ice
min
lysi
buffer
mm
triscl
mm
nacl
mm
edta
triton
ph
equal
amount
cell
lysat
incub
appropri
antibodi
overnight
follow
day
protein
aagaros
bead
sigmaaldrich
wash
ad
cell
lysat
incub
addit
h
immunoprecipit
wash
lysi
buffer
three
time
tb
final
agaros
bead
boil
sd
sampl
buffer
analyz
western
blot
correspond
antibodi
rd
cell
rd
cell
stabli
express
shh
nhk
ttr
lc
incub
chx
cultur
medium
indic
time
inhibit
de
novo
protein
synthesi
cell
collect
lyse
icecold
lysi
buffer
analysi
recombin
proteasedead
mutant
previous
describ
provid
dr
sheng
cui
institut
pathogen
biolog
chines
academi
medic
scienc
peke
union
medic
colleg
china
vitro
cleavag
assay
cell
lysat
incub
indic
amount
reaction
buffer
mm
trishcl
ph
mm
nacl
h
mixtur
analyz
immunoblot
cell
transfect
plasmid
sirna
duplex
use
lipofectamin
invitrogen
lipofectamin
rnaimax
invitrogen
respect
accord
manufactur
instruct
sirna
transfect
final
concentr
nm
sirna
purchas
guangzhou
ribobio
sequenc
shown
tabl
herp
sirna
purchas
santa
cruz
biotechnolog
unknown
sequenc
rd
cell
fix
paraformaldehyd
pb
min
permeabil
use
triton
pb
contain
bsa
sigmaaldrich
min
wash
three
time
pb
cell
incub
primari
antibodi
overnight
follow
day
cell
incub
appropri
fluorescenceconjug
secondari
antibodi
jackson
immunoresearch
h
room
temperatur
follow
dapi
nuclear
stain
imag
captur
analyz
use
tc
laserscan
confoc
microscop
la
af
softwar
leica
microsystem
total
cellular
rna
extract
use
trizol
reagent
life
technolog
accord
manufactur
protocol
one
microgram
total
rna
revers
transcrib
volum
use
impromiitm
revers
transcriptas
promega
follow
manufactur
instruct
realtim
pcr
perform
use
cdna
templat
powerup
sybr
green
master
mix
appli
biosystem
life
technolog
reaction
run
fast
realtim
pcr
machin
appli
biosystem
life
technolog
level
gene
mrna
normal
gapdh
mrna
result
analyz
foldchang
use
method
primer
rna
quantif
describ
previous
sequenc
primer
follow
herp
f
rd
cell
herp
r
rd
cell
gapdh
f
rd
cell
gapdh
r
rd
cell
vimp
f
cell
vimp
r
cell
gapdh
f
cell
gapdh
r
cell
rd
cell
grown
dish
mockinfect
infect
moi
h
cell
harvest
wash
three
time
pb
frozen
use
highpressur
freezer
leica
em
freez
substitut
perform
substitut
unit
leica
em
dri
aceton
osmium
tetroxid
h
follow
gradual
warm
h
h
wash
dri
aceton
three
time
sampl
warm
room
temperatur
infiltr
resin
sever
hour
sampl
embed
resin
place
oven
h
section
use
microtom
leica
em
ultrathin
section
stain
uranyl
acet
lead
citrat
examin
transmiss
electron
microscopi
fei
tecnai
spirit
kv
